You're probably wondering why you've never heard about Prader-Willi syndrome before. There is a simple reason for it, and ...

Patients with PWS admitted to the hospital with COVID-19 showed increased risk of in-hospital mortality, severe disease, and mechanical ventilation.

First prescriptions delivered to individuals with PWSREDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno ...

Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...

on March 26 to treat hyperphagia in patients four years of age and older with Prader-Willi syndrome (PWS), is now commercially available in the U.S. Soleno has established a comprehensive support ...

Gene variations in some people with autism strengthen the evidence for a genetic component. Among the genetic disorders ...

Aardvark Therapeutics, Inc.’s AARD share price has dipped by 8.26%, which has investors questioning if this is right time to buy.

Soleno Therapeutics (SLNO) announced the U.S. commercial availability of VYKAT XR extended-release tablets, the company’s treatment for ...

The Ford Center in Evansville was packed as police and firefighters faced off in the boxing ring. The Guns and Hoses event ...

When you're hungry, ghrelin hormone levels increase in your stomach and other parts of your body. Learn what causes its ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Amarin Corporation plc is a better investment based on AAII's A+ ...

Neuren Pharmaceuticals and its US partner Acadia have been blitzing it with the Rett syndrome treatment Daybue.